Abeona Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.

About ABEO

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). 

CEO
Vishwas Seshadri
CEOVishwas Seshadri
Employees
57
Employees57
Headquarters
Cleveland, Ohio
HeadquartersCleveland, Ohio
Founded
1974
Founded1974
Employees
57
Employees57

ABEO Key Statistics

Market cap
173.29M
Market cap173.29M
Price-Earnings ratio
-3.49
Price-Earnings ratio-3.49
Dividend yield
Dividend yield
Average volume
479.02K
Average volume479.02K
High today
$8.25
High today$8.25
Low today
$6.65
Low today$6.65
Open price
$7.89
Open price$7.89
Volume
1.40M
Volume1.40M
52 Week high
$9.01
52 Week high$9.01
52 Week low
$2.24
52 Week low$2.24
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.